I'm a pharmacokineticist focused on the experimental therapeutics of anticancer drugs. In particular we use systems-based pharmacokinetic [PK] and pharmacodynamic [PD] – systems pharmacology - approaches to advance drug development and improve drug therapy of brain tumors. We hope to identify new chemotherapeutic strategies and enhance the translational foundation of preclinical to clinical research.
Gallo Laboratory website
Multi-Disciplinary Training Area
Pharmacology and Therapeutics Discovery [PTD]Education
BS, Massachusetts College of Pharmacy
PharmD, University of Florida
PhD, University of Arizona
-
2015
New award
Systems Pharmacology of Brain Tumors
Our lab is focused on pharmacokinetic [PK]- and pharmacodynamic [PD]-directed brain tumor chemotherapy. We have incorporated systems-based methods with PK/PD methods to derive cell-type specific PK/PD and enhanced PD models that link PK and PD information at the cell and molecular scale. Ongoing projects concern anticancer drug discovery and development, oncometabolites, epigenetic modulators and tumor heterogeneity. The projects utilize a diverse array of methods that allow us to build mechanistic PK/PD models of anticancer drugs that they are scalable from preclinical models to patients. The ultimate objective of our work is to discover new targets and drugs and means to optimize multi-drug chemotherapeutic regimens.
For more information, please visit the Gallo laboratory website.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Gallo during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Roche TCRC, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.